jain.com

Operating capital needs and financing timeline

Company: CleanSpark

This claim was marked delayed on September 15, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
guidance
Statement date
2020-07-21
Promised by
2022-01-01
Current status
delayed

The claim, verbatim

Current financing expected to carry company through 2021; company needs to generate $4,000,000 to $6,000,000 annually in revenue cash flows to support operations, or will need similar additional financing in 2022.

Source (primary)

CleanSpark 424B5 filed 2020-07-22 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗

Quote: “While this financing is expected to carry us through 2021, we need to generate cashflows from revenues totaling $4,000,000 to $6,000,000 to support our current operations or we may need a similar amount in additional financing in 2022.”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms CleanSpark 424B5 filed 2020-07-22

Quote: “While this financing is expected to carry us through 2021, we need to generate cashflows from revenues totaling $4,000,000 to $6,000,000 to support our current operations or we may need a similar amount in additional financing in 2022.”

View cached copy (2026-09-13)Live source ↗

Record of changes

September 14, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 15, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.